Apogee Therapeutics
APGE
APGE
139 hedge funds and large institutions have $3.29B invested in Apogee Therapeutics in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding
Funds holding: 139 → 139 (0)
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
83% less call options, than puts
Call options by funds: $2.65M | Put options by funds: $15.2M
Holders
139
Holding in Top 10
7
Calls
$2.65M
Puts
$15.2M
Top Buyers
| 1 | +$74.5M | |
| 2 | +$36.8M | |
| 3 | +$26.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$25.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$24.4M |
Top Sellers
| 1 | -$44M | |
| 2 | -$19.6M | |
| 3 | -$12.9M | |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
-$12.5M |
| 5 |
Goldman Sachs
New York
|
-$10.6M |